In the ±90-day cohort, the difference did not reach statistical significance ( p = 0.092), although the proportion remained numerically higher in the ATB group (33.3% vs. 10.5%).
← all excerpts
Antibiotic Exposure Does Not Impact Anti-BRAF/Anti-MEK Targeted Therapy Outcome in Patients with Advanced Melanoma.
1
0.0920
0.0920